Aera Therapeutics
Aera Therapeutics is a biotech startup developing next-generation delivery systems for genetic medicines, with $193M in funding from investors including ARCH Venture Partners and Google Ventures. The company has 90 employees and focuses on lipid nanoparticles, antibody conjugates, and protein nanoparticles to improve drug delivery.
The growth story
Aera Therapeutics grew from 3 to 90 employees between 2021 and 2026, raising $193M along the way, most recently a Series B in February 2023.
About
Aera builds targeted delivery technologies for genetic medicines, addressing a key bottleneck in treatments like RNA therapies. Its platforms aim to improve precision and expand the types of diseases treatable with genetic approaches.
The company raised $193M in a 2023 Series B and employs 90 people. Its backers include top biotech investors ARCH and GV, signaling strong interest in its delivery platform approach.
Founders and leadership
Research dominates Aera's workforce, with 41 employees in that function. The company has a median tenure of 2 years, typical for a fast-growing biotech startup.
The Aera Therapeutics org chart
Akin Akinc (Chief Executive Officer) leads 27 mapped leaders with 3 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 53 (+15% YoY), Business Development 9 (+29% YoY), Information Technology 4 (+33% YoY), Engineering 3 (-40% YoY).
Talent flow
Aera recruits heavily from Alnylam Pharmaceuticals, Moderna, and Northeastern University. Alumni have moved to Eli Lilly and newer biotechs like Stylus Medicine.
Most common previous employers of Aera Therapeutics staff: Alnylam Pharmaceuticals (8), Northeastern University (6), Moderna (6), Takeda Oncology (4), bluebird bio (4), Beam Therapeutics (4). Former Aera Therapeutics employees most often moved to Eli Lilly and Company (3), Lila Sciences (2), Stylus Medicine (2), Capital One (1), Novartis (1), Harvard Medical School and Massachusetts General Hospital (1).
Alumni worth knowing
Web traffic
Traffic mix: 49% direct, 27% search, 17% social, 1% paid.
What this company is made of
Most common skills at Aera Therapeutics: Research Skills (33), Cell Culture (32), Polymerase Chain Reaction (PCR) (32), Microsoft Office (30), Molecular Biology (30), Western Blotting (28), Data Analysis (25), ELISA (25).
Where the team actually sits
Aera Therapeutics people are concentrated in Massachusetts, United States (56), Greater Boston (13), United States (5), New Hampshire, United States (1).
Search footprint
Aera Therapeutics attracts about 21 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 17 ranking keywords and lost 8 in the last period.
What employees say
- Compensation
- 4.50 / 5
- Career opportunities
- 3.10 / 5
- Senior management
- 2.60 / 5
- Work-life balance
- 2.60 / 5
Frequently asked
Aera Therapeutics has 90 employees as of September 2026.
Aera Therapeutics has raised $193M in total, most recently a Series B round in February 2023.
Akin Akinc (Chief Executive Officer) sits at the top of Aera Therapeutics's reporting structure, with 3 direct reports.
The most common previous employers of current Aera Therapeutics staff are Alnylam Pharmaceuticals (8 people), Northeastern University (6 people), Moderna (6 people).
Former Aera Therapeutics employees most often move to Eli Lilly and Company (3), Lila Sciences (2), Stylus Medicine (2).
Aera Therapeutics attracts about 21 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Aera Therapeutics staff are Research Skills, Cell Culture, Polymerase Chain Reaction (PCR), Microsoft Office, Molecular Biology.
Aera Therapeutics staff are concentrated in Massachusetts, United States (56), Greater Boston (13), United States (5).
Aera Therapeutics has about 53 people in Research, up 15% over the past year, as of September 2026.
Aera Therapeutics has about 9 people in Business Development, up 29% over the past year, as of September 2026.
Computed from 75 current and 52 former Aera Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.